Connect with us

Press Releases

Foundation Fighting Blindness and Nixon Visions Foundation Collaborate

Program to have special translational research emphasis on inherited macular dystrophy.




(PRESS RELEASE)COLUMBIA, MD — The Foundation Fighting Blindness, the world’s leading organization committed to finding treatments and cures for blinding retinal diseases, has announced the launch of the Nixon Visions Foundation Inherited Macular Dystrophy Program formed through a collaboration with the Nixon Visions Foundation. The Program will provide funding for six early translational research projects over three years for the development of new therapies that could treat inherited macular dystrophy, including visual impairment related to mutations in the PRPH2 gene.

In addition, the Foundation Fighting Blindness will partner with the University of California San Diego to conduct a workshop under the title of “Nixon Visions Foundation Inherited Macular Dystrophy Comprehensive International Workshop with Special Focus on PRPH2.” The workshop will provide a deep dive review on PRPH2-related retinal disease and related biological and therapeutic approaches, with the goal of publishing the findings for widespread dissemination.

“We are thrilled to be partnering with Brandon and Janine Nixon on this multi-faceted program. Their support of the Foundation’s mission to find treatments and cures for inherited retinal diseases is inspiring,” said Benjamin Yerxa, PhD, chief executive officer, Foundation Fighting Blindness. “This level of commitment significantly boosts our ability to drive sight-saving research.”

“The work the Foundation Fighting Blindness is doing is making a tremendous impact and will improve the lives of others for generations to come,” said Brandon Nixon, chief executive officer, Nixon Visions Foundation. “We are pleased to support the Foundation Fighting Blindness for their invaluable efforts, particularly with respect to the mission to eradicate the entire spectrum of retinal degenerative diseases with special emphasis on the PRPH2 gene.”

In coordination with the Nixon Visions Foundation, the Foundation Fighting Blindness will build awareness in the inherited retinal disease community about PRPH2 (also known as RDS, which encodes the peripherin-2 protein) mutations and its effect on blindness. Promotion of the Foundation’s patient database, My Retina Tracker® Registry, will ensure further accuracy to the size of the population that is impacted from mutations of the PRPH2 gene.




The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width3 according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion4 and seamless transitions from near to far.

For more information, visit here.

Promoted Headlines





Get the most important news and business ideas for eyecare professionals every weekday from INVISION.



Most Popular